SynAct Pharma AB

Stockholm Stock Exchange:SYNACT.ST

Location

Market Cap

USD 95.12 M

Share Price

USD 1.94

Avg Daily Volume

220,062

Change (1 day)

4.55%

Change (1 year)

186.47%

Change (YTD)

139.62%

SynAct Pharma AB Income Statement 2014 - 2024

This table shows the Income Statement for SynAct Pharma AB going from 2014 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.

Income Statement

Annual data in millions of USD, except per share data Trend

StockViz Staff

June 27, 2025

Any question? Send us an email